Company profile: Exact Therapeutics
1.1 - Company Overview
Company description
- Provider of Acoustic Cluster Therapy (ACT®), a clinical-stage, ultrasound-mediated technology platform using microbubbles and sonoporation to enhance targeted drug delivery and therapeutic uptake, aiming to amplify the clinical utility of treatments in oncology and other medical applications.
Products and services
- Acoustic Cluster Therapy (ACT®) Platform: Clinical-stage technology platform engineered to enhance targeted drug delivery via ultrasound and microbubbles, amplifying therapeutic agent uptake across oncology and other medical applications
- ACT® Sonoporation: Microbubble-based method that uses ultrasound to achieve targeted drug enhancement, improving uptake of therapeutic agents in oncology and other medical applications
- Ultrasound-Mediated Targeted Drug Enhancement: Ultrasound-mediated system that leverages ACT® to improve targeted delivery and uptake of therapeutic agents, applicable in oncology and other medical applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Exact Therapeutics
Angiex
HQ: United States
Website
- Description: Provider of vascular-targeted biotherapeutics, developing TM4SF1-directed antibody-drug conjugates for solid tumors, including AGX101, an antibody–microtubule inhibitor conjugate entering Phase 1 to target tumor cells and tumor vascular endothelium; a Nuclear Delivery Platform with antibodies, site-specific conjugation, and linkers for nucleus/cytosol delivery; and a preclinical ND-ADC pipeline using small molecule and protein degrader payloads.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Angiex company profile →
Intact Medical
HQ: United States
Website
- Description: Provider of minimally invasive systems for volumetric excision of tissue for diagnostic and therapeutic applications in select cancer markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intact Medical company profile →
Umoja Biopharma
HQ: United States
Website
- Description: Provider of next-generation immunotherapies intended to combat cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Umoja Biopharma company profile →
Alpheus Medical
HQ: United States
Website
- Description: Provider of a non-invasive sonodynamic therapy platform for solid body cancers that uses ultrasound to activate a cancer-targeting drug, including an SDT platform for outpatient treatment of recurrent high-grade gliomas and CV-01, an investigational drug-device using low-intensity, large-field ultrasound to target cancer cells across the brain hemisphere; CV-01 is in Phase 1 clinical trials for recurrent glioblastoma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alpheus Medical company profile →
Odyssey Therapeutics
HQ: United States
Website
- Description: Provider of precision immunomodulators for inflammatory diseases and oncology medicines for cancer, enabled by a drug hunting engine combining machine learning, target biology, and medicinal chemistry. Offers target biology and discovery with CRISPR-based screening and advanced cell culture, proprietary small-molecule libraries, and predictive/data sciences.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Odyssey Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Exact Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Exact Therapeutics
2.2 - Growth funds investing in similar companies to Exact Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Exact Therapeutics
4.2 - Public trading comparable groups for Exact Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →